Dark Light

Gastroenterology and Hepatology Board Review 2023 (Videos)



Gastroenterology and Hepatology Board Review is an online video CME program covering normal function, signs, symptoms, and diseases of the gastrointestinal organs — from the esophagus and stomach to the small intestine, colon, liver, pancreas, and biliary tract.
This continuing medical education program includes 40+ one-hour lectures delivered by recognized experts with extensive clinical experience. You’ll benefit from the decision-making expertise of these skilled educators as they discuss diagnostic procedures, medical therapy, surgical therapy, and procedural therapy. Presentations combine scientific evidence and clinical judgment, culminating with recommendations for the most appropriate care and improved patient outcomes.
Learning Objectives
At the conclusion of this activity, the participant will be able to:

Describe the clinical, endoscopic, and histopathologic features of eosinophilic esophagitis
Summarize resuscitation, initial management, transfusion recommendations, and timing of endoscopy for peptic ulcer bleeding
Explain the differential diagnosis, evaluation, and management of diarrhea.
Discuss inflammatory bowel disease diagnostic tools and work-up for appropriate patients
Identify the risk factors that warrant screening for hepatitis C
Recognize clinical trends in drug-induced liver injury
List the possible pathogenic mechanisms of pancreatitis and how that informs drug targets and treatments
Differentiate between acute calculous cholecystitis and acute acalculous cholecystitis
List the core principles of obesity treatment
Name the gastrointestinal manifestations of COVID-19 infection

Intended Audience
This educational activity was designed for gastroenterologists, hepatologists, internists, fellows in gastroenterology, and internal medicine residents interested in gastroenterology and hepatology.

Gastroesophageal Reflux Disease (GERD) and Barrett’s Esophagus – Stuart Jon Spechler, MD
Esophageal Motility and Structural Disorders – Dustin A. Carlson, MD
Update in Eosinophilic Esophagitis and Eosinophilic Gastrointestinal Diseases – Evan S. Dellon, MD, MPH
Esophageal Cancer – Anil K. Rustgi, MD
Stomach and Small Intestine
Pathophysiology of Peptic Ulcer Disease – Helen M. Shields, MD
Peptic Ulcer Hemorrhage – Diagnosis and Management – Dennis M. Jensen, MD
Motility Disorders – Gastroparesis, Functional Dyspepsia, Ileus – Braden Kuo, MD, MSc
Malabsorption and Nutrition – Henry J. Binder, MD
Viral/Bacterial Gastroenteritis – Jason B. Harris, MD, MPH

Constipation and Diarrhea – Lawrence R. Schiller, MD
Celiac Disease and Gluten Sensitivity – Peter H. R. Green, MD
Diagnosis and Management of Clostridioides difficile Infections – Jessica R. Allegretti, MD, MPH
Inflammatory Bowel Disease – Anita Afzali, MD, MPH, MHCM

Irritable Bowel Syndrome – Walter W. Chan, MD, MPH, FACG, AGAF

Ischemic Bowel Disorders – A Case Based Approach – Paul Feuerstadt, MD
Colorectal Cancer Screening Strategies – Shilpa Grover, MD, MPH
An Update on Colorectal and Anal Cancers – Robert J. Mayer, MD
Hereditary Gastrointestinal Polyposis/Cancer Syndromes – John M. Carethers, MD, MACP

Liver – Hepatitis
Viral Hepatitis Overview – Raymond T. Chung, MD
Hepatitis B – Norah Terrault, MD, MPH
Hepatitis C – Ira M. Jacobson, MD
HIV – Viral Hepatitis Co-Infection – Kenneth E. Sherman, MD, PhD
Liver – General
Drug-Induced Liver Injury – Idiosyncratic (iDILI) and Acetaminophen – William M. Lee, MD, FACP, FAASLD, AGAF
Nonalcoholic Fatty Liver Disease – Stephen A. Harrison, MD
Alcohol-Associated Hepatitis – Jay Luther, MD
Autoimmune Liver Disorders – John M. Vierling, MD, FACP, FAASLD, AGAF
Genetic Liver Disorders – Kris V. Kowdley, MD, FACP

Hepatic Decompensation – Andrea Ewing Reid, MD, MPH
Hepatocellular Carcinoma – Augusto Villanueva, MD
Liver Transplantation – Thomas D. Schiano, MD
Liver Fibrosis – Don C. Rockey, MD
Acute Pancreatitis – Yasmin Genevieve Hernandez-Barco, MD
Recurrent-Chronic Pancreatitis – Evaluation and New Therapies – Steven D. Freedman, MD, PhD
Update in Pancreatic Cancer – William R. Brugge, MD
Biliary Tract
Gallstones, Gallbladder, and Biliary Tract Disease – Muthoka L. Mutinga, MD
Cholangiocarcinoma – Sumera I. Ilyas, MD
Special Topics
Gut Microbiome – Aonghus Lavelle, MD, PhD

Approach to Gastrointestinal Hemorrhage – John R. Saltzman, MD
A New Era in Obesity Treatment – Lee M. Kaplan, MD, PhD
COVID-19 – Gastrointestinal Manifestations – Thomas R. McCarty, MD
Gastrointestinal and Hepatic Toxicities of Checkpoint Blockade – Michael Dougan, MD
Acute Gastrointestinal Toxicity of Novel Anti-Cancer Therapies – Shilpa Grover, MD, MPH
Date of Original Release: August 31, 2023